No abstract available
MeSH terms
-
Anti-Inflammatory Agents / therapeutic use*
-
Betacoronavirus / drug effects*
-
COVID-19
-
Cannabidiol / therapeutic use*
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / pathology
-
Cytokine Release Syndrome / drug therapy
-
Cytokine Release Syndrome / prevention & control
-
Humans
-
Inflammation / drug therapy*
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / pathology
-
SARS-CoV-2
Substances
-
Anti-Inflammatory Agents
-
Cannabidiol